Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 14,136.4 | 12,454.7 | 13,075.9 | 12,343.8 | 14,197.6 | -5,071.4 | 13,300.7 | 12,891.4 |
| Revenue growth | 13.5% | -4.8% | 5.9% | -13.1% | -380.0% | -138.1% | 3.2% | 4.4% |
| Cost of goods sold | 9,639.8 | 8,575.6 | 9,032.9 | 8,582.5 | 9,811.6 | -9,307.9 | 9,277.4 | 8,982.8 |
| Gross profit | 4,496.6 | 3,879.1 | 4,043.0 | 3,761.3 | 4,386.0 | 4,236.5 | 4,023.3 | 3,908.6 |
| Gross margin | 31.8% | 31.1% | 30.9% | 30.5% | 30.9% | -83.5% | 30.2% | 30.3% |
| Selling, general and administrative | 2,446.3 | 2,270.6 | 2,320.3 | 2,249.2 | 2,720.7 | 2,597.8 | 2,531.6 | 2,503.9 |
| EBITA | 2,173.9 | 1,749.1 | 1,839.4 | 1,672.4 | 1,859.0 | 1,770.7 | 1,676.0 | 1,545.5 |
| EBITA margin | 15.4% | 14.0% | 14.1% | 13.5% | 13.1% | -34.9% | 12.6% | 12.0% |
| Amortization of intangibles | 123.6 | 115.7 | 116.7 | 116.8 | 132.0 | 132.0 | 150.2 | 128.3 |
| EBIT | 2,050.3 | 1,633.4 | 1,722.7 | 1,555.6 | 1,727.0 | 1,638.7 | 1,525.8 | 1,417.2 |
| EBIT margin | 14.5% | 13.1% | 13.2% | 12.6% | 12.2% | -32.3% | 11.5% | 11.0% |
| Pre-tax income | 1,790.7 | 1,288.2 | 1,398.9 | 1,257.8 | 1,417.9 | 1,741.3 | 1,247.9 | 1,209.4 |
| Income taxes | 333.5 | 296.8 | 238.6 | 234.9 | 80.2 | 281.5 | 540.8 | 293.7 |
| Tax rate | 18.6% | 23.0% | 17.1% | 18.7% | 5.7% | 16.2% | 43.3% | 24.3% |
| Earnings from continuing ops | 2,914.4 | 1,982.8 | 1,160.3 | 1,022.9 | 2,665.7 | 1,443.3 | 1,396.0 | 897.0 |
| Earnings from discontinued ops | -20.6 | -121.4 | 268.2 | 334.6 | -25.4 | 32.9 | -24.3 | 34.7 |
| Net income | 2,893.8 | 1,861.4 | 1,428.5 | 1,357.5 | 2,640.3 | 1,476.2 | 1,371.7 | 931.7 |
| Net margin | 20.5% | 14.9% | 10.9% | 11.0% | 18.6% | -29.1% | 10.3% | 7.2% |
| |
| Diluted EPS | $12.03 | $8.16 | $4.75 | $4.09 | $10.33 | $5.52 | $5.21 | $3.27 |
| Shares outstanding (diluted) | 242.3 | 243.1 | 244.4 | 250.1 | 258.1 | 261.7 | 267.8 | 274.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|